1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Patient Monitoring Device Market Trends
  5. > Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) - Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts, 2012 - 2020

Rise in incidence of diabetes across the globe has elevated the need of innovative diabetic management devices that has increased adoption of continuous glucose monitoring (CGM) devices. The existing glucose monitoring devices have few gaps which are bridged by the innovative CGM. With continuous glucose monitoring, significant improvement has been observed in stabilizing elevated A1C levels which in turn reduces risk of developing long term diabetic complications. Other driving factors for CGM market are technological innovation in the form of artificial pancreas, increasing awareness among developed, developing and under developed economies, and rise in incidences of diabetic cases. However, factors such as strict regulatory impositions, inadequate reimbursement options for CGM and accuracy as well as cost of the CGMs are restraining the market growth.The global continuous glucose monitors market generated revenue of $194.8 million in 2012 and is expected to reach market size of value $568.5 million by 2020, growing at a CAGR of 14.8% during 2013-2020. This growth is attributed to increase in technological innovations, namely launch of artificial pancreas, convenience offered by CGM over self monitoring glucose devices, and earlier detection of the hypo & hyperglycemic events by CGM.Global CGM market is segmented based on application as home settings, diagnostics and hospitals. Among all the application segments home settings is expected to generate maximum revenue by 2020.North America is the maximum revenue-generating segment across the globe, mainly due to rapid acceptance of innovative technology, well-penetrated reimbursement system when compared with other geographies and rise in patient pool. Asia Pacific is expected to grow at a faster rate due to large patient pool, geographical expansion of market players, increase in income levels and improved living standards of the people.Key market players in this market includes, Medtronics, Dexcom, Animas Corporation, Ypsomed AG, Omnipod and Miraculins, Inc inlcuding others. The major strategy adopted the market players across this geography is Collaborations, Product launches and approvals. Collaborations specifically focus on distribution and commercialization of the devices.

KEY BENEFITS
The report ranks the factors that are responsible to accelerate the market growth driven by upper hand of CGM over Self monitoring glucose devices, approval for artificial pancreas and many moreMarket is forecasted for period of seven years 2013 to 2020 with market revenues for 2 historic years of 20110and 2012Identification and analysis of key pockets of investment for CGM manufacturersIdentification of challenges that must be addressed and overcome in the CGM market to achieve fiscal success throughout the marketAnalysis of regulatory framework that regulates introduction of new CGM and puts light on reimbursement scenarioThe report identifies and profiles key market participants that would drive innovation in the CGM market

KEY MARKET SEGMENTS
GLOBAL MARKET, BY DEVICESTransmitter and ReceiversSensorsInsulin PumpGLOBAL MARKET, BY APPLICATIONDiagnostics/ClinicsHospitalsHome SettingsGLOBAL MARKET, BY AGEChildren and TeensYouthMiddle, Elderly and AgedGLOBAL MARKET,

BY GEOGRAPHY
North AmericaEuropeAsia PacificRow

KEY AUDIENCES
Medical Devices ManufacturersResearch InstitutionsHealthcare Institutions

Table Of Contents

Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) - Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts, 2012 - 2020
CHAPTER 1 INTRODUCTIONandnbsp;1.1 Objectives and Scopeandnbsp;1.2 Report Descriptionandnbsp;1.3 Key Benefits of the Reportandnbsp;1.4 Research MethodologyCHAPTER 2 EXECUTIVE SUMMARYCHAPTER 3 GLOBAL CONTINUOUS GLUCOSE MONITORS MARKET OVERVIEWandnbsp;3.1 Healthcare Expenditure on Diabetes Worldwideandnbsp;3.2 Type-1 Diabetics to Remain Key Target for CGM Marketandnbsp; andnbsp; 3.2.1 Type-1 Diabetesandnbsp; andnbsp; andnbsp; andnbsp;3.2.1.1 Type-1 Diabetes in Young Peopleandnbsp; andnbsp; 3.2.2 Type-2 Diabetesandnbsp; andnbsp; andnbsp; andnbsp;3.2.2.1 Type-2 Diabetes in Young Peopleandnbsp; andnbsp; 3.2.3 Gestational Diabetesandnbsp; andnbsp; 3.2.4 Other Types of Diabetesandnbsp;3.3 Market Intelligence andnbsp;andnbsp; andnbsp; 3.3.1 Top Factors Impacting Continuous Glucose Monitors Market, 2013-2020andnbsp; andnbsp; andnbsp; andnbsp;3.3.1.1 Fda Approval of Artificial Pancreasandnbsp; andnbsp; andnbsp; andnbsp;3.3.1.2 Convenience Offered by CGM Over Self Monitoring Glucose Devicesandnbsp; andnbsp; andnbsp; andnbsp;3.3.1.3 Rise in Incidences of Diabetes Cases Globallyandnbsp; andnbsp; andnbsp; andnbsp;3.3.1.4 Earlier Detection of the Hypo and Hyperglycemic Events by CGMandnbsp; andnbsp; andnbsp; andnbsp;3.3.1.5 Inadequate Reimbursement Options for CGM Serve as Barriers for its Adoptionandnbsp; andnbsp; andnbsp; andnbsp;3.3.1.6 Accuracy and Cost Acts as a Hindrance in Continuing Use of CGMandnbsp; andnbsp; andnbsp; andnbsp;3.3.1.7 Strict Regulatory Impositionsandnbsp; andnbsp; andnbsp; andnbsp;3.3.1.8 Increase in Awareness Among Developing and Underdeveloped Economiesandnbsp; andnbsp; 3.3.2 Top Three Winning Strategies in the Continuous Glucose Monitors Marketandnbsp; andnbsp; andnbsp; andnbsp;3.3.2.1 Global Market Players Positioningandnbsp; andnbsp; 3.3.3 Top Investment Pockets in Continuous Glucose Monitors Marketandnbsp; andnbsp; andnbsp; andnbsp;3.3.3.1 Continuous Glucose Monitors Market anddash; by Deviceandnbsp; andnbsp; andnbsp; andnbsp;3.3.3.2 Continuous Glucose Monitors Market anddash; by Applicationsandnbsp; andnbsp; andnbsp; andnbsp;3.3.3.3 Continuous Glucose Monitors Market anddash; by Geographyandnbsp;3.4 Regulationsandnbsp;3.5 Reimbursement Scenarioandnbsp;3.6 Market Dynamicsandnbsp; andnbsp; 3.6.1 Driversandnbsp; andnbsp; andnbsp; andnbsp;3.6.1.1 Convenience Offered by CGM Over Self Monitoring Glucose Devicesandnbsp; andnbsp; andnbsp; andnbsp;3.6.1.2 FDA Approval of Artificial Pancreas Enables Closing the Loop and Overcomes the Limitation of Current Diabetes Care Management Systemandnbsp; andnbsp; andnbsp; andnbsp;3.6.1.3 Earlier Detection of the Hypo and Hyperglycemic Events by CGMandnbsp; andnbsp; andnbsp; andnbsp;3.6.1.4 Rise in Incidences of Diabetes Cases Globallyandnbsp; andnbsp; andnbsp; andnbsp;3.6.1.5 Increase in Awareness Among the Population in Developing and Underdeveloped Economiesandnbsp; andnbsp; 3.6.2 Restraintsandnbsp; andnbsp; andnbsp; andnbsp;3.6.2.1 Strict Regulatory Impositionsandnbsp;andnbsp; andnbsp; andnbsp; andnbsp;3.6.2.2 Inadequate Reimbursement Options for CGM Serve as Barriers for its Adoptionandnbsp; andnbsp; andnbsp; andnbsp;3.6.2.3 Accuracy and Cost Acts as a Hindrance in Continuing Use of CGMandnbsp; andnbsp; 3.6.3 Market Opportunityandnbsp; andnbsp; andnbsp; andnbsp;3.6.3.1 Growth in Emerging Marketandnbsp; andnbsp; 3.6.4 Winning Strategies for Mncs in Emerging Marketsandnbsp; andnbsp; andnbsp; andnbsp;3.6.4.1 Tailoring the Existing Products to the Local Market Needsandnbsp; andnbsp; andnbsp; andnbsp;3.6.4.2 Adoption of a Proactive Hybrid Model Rather Than Distributor Managementandnbsp; andnbsp; andnbsp; andnbsp;3.6.4.3 Service Rendered Makes a Differenceandnbsp; andnbsp; andnbsp; andnbsp;3.6.4.4 Partnership and Acquisition Key to Enhance Reach and Market Positionandnbsp; andnbsp; andnbsp; andnbsp;3.6.4.5 andnbsp;Adopting An Emerging-Market AttitudeCHAPTER 4 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET - BY DEVICESandnbsp;4.1 Transmitter and Receiversandnbsp;4.2 Sensorsandnbsp; andnbsp; 4.2.1 Market Trendandnbsp; andnbsp; andnbsp; andnbsp;4.2.1.1 Non-Invasive Glucose Sensorsandnbsp; andnbsp; andnbsp; andnbsp;4.2.1.2 Subcutaneous Sensors (Minimally Invasive Sensors)andnbsp; andnbsp; andnbsp; andnbsp;4.2.1.3 Conventional Technology anddash; Holter-Type Retrospective Sensorsandnbsp; andnbsp; andnbsp; andnbsp;4.2.1.4 Advanced Technology anddash; Real-Time Sensorsandnbsp;4.3 Insulin Pumpandnbsp; andnbsp; 4.3.1 Advantages of Insulin Pumpandnbsp; andnbsp; 4.3.2 Disadvantages of Insulin Pumpandnbsp; andnbsp; 4.3.3 Market TrendCHAPTER 5 CONTINUOUS GLUCOSE MONITORING SYSTEM MARKET - BY APPLICATIONandnbsp;5.1 Diagnostics/Clinicsandnbsp;5.2 Hospitalsandnbsp;5.3 Home Settingsandnbsp;5.4 Role of CGM in Private Practiceandnbsp; andnbsp; 5.4.1 Team Membersandnbsp; andnbsp; 5.4.2 Clinical Spaceandnbsp; andnbsp; 5.4.3 Schedulingandnbsp; andnbsp; 5.4.4 Keeping the Patients InformedCHAPTER 6 CONTINUOUS GLUCOSE MONITORING SYSTEM MARKET anddash; BY AGEandnbsp;6.1 Children and Teensandnbsp;6.2 Youthandnbsp;6.3 Middle Elderly and AgedCHAPTER 7 CGM SYSTEMS MARKET BY GEOGRAPHYandnbsp;7.1 North Americaandnbsp;7.2 Europeandnbsp; andnbsp; 7.2.1 Financial Cost Incurredandnbsp;7.3 Asia Pacificandnbsp;7.4 RowCHAPTER 8 COMPANY PROFILESandnbsp;8.1 Medtronic Inc.andnbsp; andnbsp; 8.1.1 Company Overviewandnbsp; andnbsp; 8.1.2 Company Snapshotandnbsp; andnbsp; 8.1.3 Business Performanceandnbsp; andnbsp; 8.1.4 Strategic Moves and Developmentsandnbsp; andnbsp; andnbsp; andnbsp;8.1.4.1 Principal Strategies: Product Launchandnbsp; andnbsp; andnbsp; andnbsp;8.1.4.2 Secondary Strategies: Approvalandnbsp; andnbsp; andnbsp; andnbsp;8.1.4.3 Other Strategies: Collaborationandnbsp; andnbsp; 8.1.5 SWOT Analysis andamp; Strategic Conclusionsandnbsp;8.2 Dexcom Inc.andnbsp; andnbsp; 8.2.1 Company Overviewandnbsp; andnbsp; 8.2.2 Company Snapshotandnbsp; andnbsp; 8.2.3 Business Performanceandnbsp; andnbsp; 8.2.4 Strategic Moves and Developmentsandnbsp; andnbsp; andnbsp; andnbsp;8.2.4.1 Principal Strategies: Agreement/Partnershipandnbsp; andnbsp; andnbsp; andnbsp;8.2.4.2 Secondary Strategies: Acquisitionandnbsp; andnbsp; 8.2.5 SWOT Analysis andamp; Strategic Conclusionsandnbsp;8.3 Novo Nordiskandnbsp; andnbsp; 8.3.1 Company Profileandnbsp; andnbsp; 8.3.2 Company Snapshotandnbsp; andnbsp; 8.3.3 Strategic Moves and Developmentsandnbsp; andnbsp; 8.3.4 SWOT Analysis andamp; Strategic Conclusionsandnbsp;8.4 Spring Health Solution Ltdandnbsp; andnbsp; 8.4.1 Company Profileandnbsp; andnbsp; 8.4.2 Company Snapshotandnbsp; andnbsp; 8.4.3 Strategic Moves and Developmentsandnbsp; andnbsp; andnbsp; andnbsp;8.4.3.1 Principal Strategiesandnbsp; andnbsp; 8.4.4 SWOT Analysis andamp; Strategic Conclusionsandnbsp;8.5 Rocheandnbsp; andnbsp; 8.5.1 Company Profileandnbsp; andnbsp; 8.5.2 Company Snapshotandnbsp; andnbsp; 8.5.3 Strategic Moves and Developmentsandnbsp; andnbsp; 8.5.4 SWOT Analysis andamp; Strategic Conclusionsandnbsp;8.6 Animas Corporationandnbsp; andnbsp; 8.6.1 Company Profileandnbsp; andnbsp; 8.6.2 Company Snapshotandnbsp; andnbsp; 8.6.3 Strategic Moves and Developmentsandnbsp; andnbsp; andnbsp; andnbsp;8.6.3.1 Principal Strategiesandnbsp; andnbsp; 8.6.4 SWOT Analysis andamp; Strategic Conclusionsandnbsp;8.7 Ypsomed AGandnbsp; andnbsp; 8.7.1 Company Profileandnbsp; andnbsp; 8.7.2 Company Snapshotandnbsp; andnbsp; 8.7.3 Strategic Moves and Developmentsandnbsp; andnbsp; andnbsp; andnbsp;8.7.3.1 Principal Strategies: Product Expansionandnbsp; andnbsp; andnbsp; andnbsp;8.7.3.2 Secondary Strategies: New Subsidiaryandnbsp; andnbsp; andnbsp; andnbsp;8.7.3.3 Other Strategies: Acquisition and Agreementsandnbsp; andnbsp; 8.7.4 SWOT Analysis andamp; Strategic Conclusionsandnbsp;8.8 Insulet Corporationandnbsp; andnbsp; 8.8.1 Company Profileandnbsp; andnbsp; 8.8.2 Company Snapshotandnbsp; andnbsp; 8.8.3 Strategic Moves and Developmentsandnbsp; andnbsp; andnbsp; andnbsp;8.8.3.1 Principal Strategiesandnbsp; andnbsp; 8.8.4 SWOT Analysis andamp; Strategic ConclusionsLIST OF TABLES:TABLE 1 FEATURES OF CURRENTLY AVAILABLE STAND-ALONE CGM SYSTEMS (AS OF MARCH 2013)TABLE 2 FEATURES OF CURRENTLY AVAILABLE INTEGRATED CGM SYSTEMS (AS OF MARCH 2013)TABLE 3 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY PRODUCT CATEGORY, 2011-2020, ($MILLION)TABLE 4 GLOBAL CGM TRANSMITTERS AND RECEIVERS MARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION)TABLE 5 GLOBAL CGM SENSORS MARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION)TABLE 6 GLOBAL CGM INSULIN PUMP MARKET BY GEOGRAPHY, 2011 - 2020, ($MILLION)TABLE 7 GLOBAL CGM MARKET BY APPLICATION SEGMENTS, 2011 - 2020, ($MILLION)TABLE 8 GLOBAL CGM MARKET IN DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2011 - 2020, ($THOUSAND)TABLE 9 GLOBAL CGM MARKET IN HOSPITALS, BY GEOGRAPHY, 2011 - 2020, ($THOUSAND)TABLE 10 GLOBAL CGM MARKET IN HOME SETTINGS, BY GEOGRAPHY, 2011 - 2020, ($MILLION)TABLE 11 GLOBAL CGM MARKET BY AGE, 2011 - 2020, ($MILLION)TABLE 12 TYPE-1 DIABETES (0-14 YEARS), 2013TABLE 13 FACTORS IMPACTING GEOGRAPHICAL REGIONS IN 2013 AND 2020TABLE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS BY GEOGRAPHY, 2011 - 2020, ($MILLION)TABLE 15 THE PREVALENCE OF DIABETES IN THE ADULT POPULATION ACROSS THE U.K. IN 2011TABLE 16 PREVALENCE ESTIMATES OF DIABETES (20-79 YEARS), 2013, EUROPETABLE 17 PREVALENCE ESTIMATES OF DIABETES, 2013 andamp; 2035TABLE 18 PREVALENCE ESTIMATES OF DIABETES (20-79 YEARS), 2013, AFRICA REGIONTABLE 19 MEDTRONIC BUSINESS SNAPSHOTTABLE 20 DEXCOM INC. BUSINESS SNAPSHOTTABLE 21 NOVA NORDISK BUSINESS SNAPSHOTTABLE 22 SPRING HEALTH SOLUTION LTD BUSINESS SNAPSHOTTABLE 23 ROCHE BUSINESS SNAPSHOTTABLE 24 ANIMAS CORPORATION BUSINESS SNAPSHOTTABLE 25 YPSOMED AG BUSINESS SNAPSHOTTABLE 26 INSULET CORPORATION BUSINESS SNAPSHOTLIST OF FIGURES:FIG. 1 GLOBAL HEALTH EXPENDITURE DUE TO DIABETES, BY GEOGRAPHY ($BILLION)FIG. 2 GLOBAL HEALTH EXPENDITURE DUE TO DIABETES, 20-79 YEARS ($BILLION)FIG. 3 TREATMENT OF DIABETES, 2011FIG. 4 SIMILARITIES IN CAUSE OF PRE-DIABETES AND TYPE-2 DIABETESFIG. 5 CGM ADOPTION BY DIFFERENT TYPES OF DIABETES PATIENTSFIG. 6 PREVALENCE OF TYPE-1 DIABETES, BY GEOGRAPHY, (THOUSAND)FIG. 7 GLOBAL PREVALENCE OF TYPE-2 DIABETES IN 2000 andamp; ESTIMATED PREVALENCE IN 2030FIG. 8 TOP FACTORS IMPACTING CGM MARKET, 2013-2020FIG. 9 TOP WINNING STRATEGY IN CGM MARKET, 2010 TO 2013 (SEPTEMBER)FIG. 10 TOP WINNING STRATEGY IN CGM MARKET BY YEARFIG. 11 GLOBAL MARKET PLAYERS POSITIONINGFIG. 12 TOP INVESTMENT POCKETS IN CGM DEVICE MARKETSFIG. 13 TOP INVESTMENT POCKETS IN CGM APPLICATION MARKETSFIG. 14 TOP INVESTMENT POCKETS IN CGM GEOGRAPHY MARKETSFIG. 15 NUMBER OF INCIDENCES OF DIABETES GLOBALLY, BY GEOGRAPHY (2000, 2011 andamp; 2030)FIG. 16 GDP PER CAPITA IN EMERGING ECONOMIESFIG. 17 EMERGING MARKET CAPITALIZATION STRATEGIESFIG. 18 GLOBAL CGM MARKET AMONG CHILDREN, 2011-2020, ($MILLION)FIG. 19 GLOBAL CGM MARKET AMONG TEENS, 2011-2020, ($MILLION)FIG. 20 GLOBAL CGM MARKET AMONG YOUTH, 2011-2020, ($MILLION)FIG. 21 GLOBAL CGM MARKET AMONG MIDDLE ELDERLY, 2011-2020, ($MILLION)FIG. 22 GLOBAL CGM MARKET AMONG AGED, 2011-2020, ($MILLION)FIG. 23 NORTH AMERICA CGM MARKET, 2013-2020, ($MILLION)FIG. 24 CASES OF DIABETES BY AGES IN NAC (1000S) (2013 E)FIG. 25 EUROPE CGM MARKET, 2013-2020, ($MILLION)FIG. 26 CASES OF DIABETES BY AGES IN EUROPE (1000S) (2013 E)FIG. 27 ASIA PACIFIC CGM MARKET, 2013-2020, ($MILLION)FIG. 28 TOP 10 COUNTRIES WITH DIABETES INCIDENCES 2013 AND 2035FIG. 29 ROW CGM MARKET, 2013-2020, ($MILLION)FIG. 30 FINANCIAL REVENUES BY BUSINESS UNITS (2013)FIG. 31 FINANCIAL REVENUES BY GEOGRAPHY (2013)FIG. 32 FINANCIAL REVENUES BY GEOGRAPHY (2012)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
European Market Report for Continuous Glucose Monitoring 2016 - MedCore

European Market Report for Continuous Glucose Monitoring 2016 - MedCore

  • $ 5495
  • Industry report
  • September 2016
  • by iData Research, Inc.

The European CGM market comprises the CGM system segment and the CGM sensor segment. The business model for CGM is similar to traditional blood glucose meters, where the CGM system is the base equipment ...

US Market Report for Blood Glucose Test Strips 2017 - MedCore

US Market Report for Blood Glucose Test Strips 2017 - MedCore

  • $ 5495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The U.S. blood glucose test strip market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose test strip market ...

US Market Report for Continuous Glucose Monitoring 2017 - MedCore

US Market Report for Continuous Glucose Monitoring 2017 - MedCore

  • $ 5495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The U.S. continuous glucose monitoring (CGM) market can be segmented by setting, yielding two segments: professional CGM and personal CGM. In 2016, the largest segment in the total CGM market ...

Germany Diabetes Devices Market

October 2016 $ 3250

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.